To determine the potential involvement of MAPKs in docetaxel-induced PHD1 phosphorylation in cancer cells under hypoxia, we first used immunoblot analyses to examine MAPK protein and activation levels before and after docetaxel treatment. This evidence concerns the gene EGLN2 and cancer.